Top Markets
#1 GEKKO GEKKO +51.79%
#2 ADO Protocol ADO Protocol +38.56%
#3 Pons Pons +32.20%
#4 Helium Helium +28.69%
#5 TENDIES TENDIES +21.80%
#6 Giggle Fund Giggle Fund +20.11%
#7 OpenGradient OpenGradient +19.68%
#8 Prom Prom +18.47%
#9 龙虾 (Lobster) 龙虾 (Lobster) +17.88%
#10 Main Street Yield Main Street Yield +17.48%
Coin of the day
GEKKO GEKKO
Settings
Language
ENGLISH
Currency
USD
Theme
GC Biopharma Corp. GC Biopharma Corp.

GC Biopharma Corp.

006280
Rank in Stocks #9359
GC Biopharma Corp. is a pharmaceutical enterprise primarily involved in the... GC Biopharma Corp. is a pharmaceutical enterprise primarily involved in the production and distribution of various medical products. Its extensive portfolio encompasses specialized treatments for blood-related conditions, non-prescription remedies, general medications, and immunizations, among other therapeutic solutions. The company was established on November 1, 1969, and its principal corporate offices are situated in Yongin, South Korea.
Share Price
$90.24
Last synced: 2026-08-28
Market Cap
$1.03B
Change (1 day)
2.68%
Change (1 year)
-3.36%
Country
KR
Trade GC Biopharma Corp. (006280)

Category

Healthcare
Revenue for GC Biopharma Corp. (006280)
Revenue in Aug 2026 TTM: 0
According to GC Biopharma Corp. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for GC Biopharma Corp. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 $4.55B -
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT